Search research articles
Contact Us
Filters
Showing results (11-20 of 339) with videos related to
Page
of 34
Sort By:
Atherosclerosis
|
December 30, 2011
HMGB1 signals danger in acute coronary syndrome: emergence of a new risk marker for cardiovascular death?
Karlheinz Peter, Alex Bobik
Cardiovascular Research
|
April 1, 2021
Platelets, coagulation, and the vascular wall: the quest to better understand and smarten up our therapeutic targeting of this triad in primary and secondary prevention of cardiovascular events
Bianca Rocca, Karlheinz Peter
Thrombosis and Haemostasis
|
February 29, 2012
GPIIb/IIIa inhibitors: from bench to bedside and back to bench again
Paul C Armstrong, Karlheinz Peter
Current Pharmaceutical Design
|
January 21, 2011
Targeting the platelet integrin GPIIb/IIIa
Christoph E Hagemeyer, Karlheinz Peter
Atherosclerosis
|
June 27, 2015
Determining the characteristics of human atherosclerosis: A difficult but indispensable task providing the direction and proof of concept for pioneering atherosclerosis research in animal models
Yung Chih Chen, Karlheinz Peter
Cardiovascular Research
|
September 2, 2021
The known knowns and known unknowns of vaccine-induced thrombotic thrombocytopaenia
James D McFadyen, Karlheinz Peter
Cardiovascular Research
|
December 28, 2020
Platelet CXCL14: introducing a new player and potential therapeutic target in thromboinflammation
James D McFadyen, Karlheinz Peter
Proteomics. Clinical Applications
|
July 1, 2014
Biomarkers for AAA: Encouraging steps but clinical relevance still to be delivered
Nay Min Htun, Karlheinz Peter
Circulation Research
|
March 15, 2019
Molecular Positron Emission Tomography in Cardiac Ischemia/Reperfusion
May Lin Yap, Karlheinz Peter
Thrombosis and Haemostasis
|
July 26, 2021
MicroRNAs as Biomarkers for Personalized Antiplatelet Therapy
Mitchell J Moon, Karlheinz Peter
Page
of 34
Search research articles
Search
Showing results (11-20 of 339) with videos related to
Sort By:
Page
of 34
Atherosclerosis
|
December 30, 2011
HMGB1 signals danger in acute coronary syndrome: emergence of a new risk marker for cardiovascular death?
Karlheinz Peter, Alex Bobik
Cardiovascular Research
|
April 1, 2021
Platelets, coagulation, and the vascular wall: the quest to better understand and smarten up our therapeutic targeting of this triad in primary and secondary prevention of cardiovascular events
Bianca Rocca, Karlheinz Peter
Thrombosis and Haemostasis
|
February 29, 2012
GPIIb/IIIa inhibitors: from bench to bedside and back to bench again
Paul C Armstrong, Karlheinz Peter
Current Pharmaceutical Design
|
January 21, 2011
Targeting the platelet integrin GPIIb/IIIa
Christoph E Hagemeyer, Karlheinz Peter
Atherosclerosis
|
June 27, 2015
Determining the characteristics of human atherosclerosis: A difficult but indispensable task providing the direction and proof of concept for pioneering atherosclerosis research in animal models
Yung Chih Chen, Karlheinz Peter
Cardiovascular Research
|
September 2, 2021
The known knowns and known unknowns of vaccine-induced thrombotic thrombocytopaenia
James D McFadyen, Karlheinz Peter
Cardiovascular Research
|
December 28, 2020
Platelet CXCL14: introducing a new player and potential therapeutic target in thromboinflammation
James D McFadyen, Karlheinz Peter
Proteomics. Clinical Applications
|
July 1, 2014
Biomarkers for AAA: Encouraging steps but clinical relevance still to be delivered
Nay Min Htun, Karlheinz Peter
Circulation Research
|
March 15, 2019
Molecular Positron Emission Tomography in Cardiac Ischemia/Reperfusion
May Lin Yap, Karlheinz Peter
Thrombosis and Haemostasis
|
July 26, 2021
MicroRNAs as Biomarkers for Personalized Antiplatelet Therapy
Mitchell J Moon, Karlheinz Peter
Page
of 34